As expected, IL-21 promoted the proliferation of Nalm-6 cells and patient B-ALL cells, suggesting that it should work together with IL-17A to facilitate the expansion of B-ALL cells. The gene discussed is IL17A; the disease is acute lymphoblastic leukemia.